Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Receivables (2016 - 2025)

Historic Receivables for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $47.8 million.

  • Veracyte's Receivables fell 201.0% to $47.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.8 million, marking a year-over-year decrease of 201.0%. This contributed to the annual value of $46.5 million for FY2024, which is 1522.36% up from last year.
  • Veracyte's Receivables amounted to $47.8 million in Q3 2025, which was down 201.0% from $50.8 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Receivables registered a high of $53.8 million during Q1 2025, and its lowest value of $27.9 million during Q1 2021.
  • For the 5-year period, Veracyte's Receivables averaged around $43.2 million, with its median value being $42.5 million (2022).
  • Per our database at Business Quant, Veracyte's Receivables surged by 12865.17% in 2021 and then tumbled by 827.56% in 2023.
  • Over the past 5 years, Veracyte's Receivables (Quarter) stood at $41.5 million in 2021, then increased by 6.17% to $44.0 million in 2022, then dropped by 8.28% to $40.4 million in 2023, then grew by 15.22% to $46.5 million in 2024, then rose by 2.8% to $47.8 million in 2025.
  • Its Receivables was $47.8 million in Q3 2025, compared to $50.8 million in Q2 2025 and $53.8 million in Q1 2025.